© 2021 Stock Analysis. Compass was funded in their seed round by ATAI at a then $15 million valuation, which was clearly a great move by ATAI. CMPS has 36.67 million shares outstanding. Analysts covering Compass Pathways currently have a consensus Earnings Per Share (EPS) forecast of -1.825 for the next financial year. Currently, Palantir is one of the tech industry’s most valuable private companies with a whopping valuation of $20 billion dollars. The financing will encompass 6.7 million American Depository Shares, priced between $14 and $16. Although we expect Compass Pathways to proactively diversify its therapeutic pipeline in the coming months—as referenced in Form F1—the company has yet to go shopping. COMPASS Pathways General Information Description. In September, the company he helped found in 2017, Compass Pathways, which has developed a synthetic version of psilocybin (the active ingredient in magic mushrooms) and is conducting the world’s first large-scale therapy clinical trial using the drug, listed in New York. CMPS has a market cap or net worth of $1.27 billion. Other market data is delayed by at least 15 minutes. COMPASS team. Their latest funding was raised on Apr 27, 2020 from a Series B round. This risk-adjusted value gives Compass currently around a $703.7B valuation. Compass Pathways PLC ADR CMPS Morningstar Rating Rating as of Apr 16, 2021. This is above the original quoted range of between $14 and $16 per share. Executive Team. Our first programme is researching how psilocybin therapy could help people with treatment-resistant depression. As a private player (with limited access to capital), Compass was limited to drug research alone. IPO fever drives Compass to a high valuation, investors will (as always) start shopping further down the food chain, looking for value. Using a peak sales multiple of 3, the intrinsic value of the COMPASS Pathways should be around US$450-500M, which is very close to the IPO valuation of the company. The updated price values the company over $750 million. Compass is seeking to raise up to $107.2 million as it prepares to list on the NASDAQ (symbol “CMPS”). Compass had priced their shares at $17.00 for total gross proceeds of $127.5 million. Altogether, Compass will have 34.01 million shares outstanding by its IPO date. CMPS does not appear to pay any dividends at this time. UK-based Compass Pathways led a groundbreaking IPO last week. The next estimated earnings date is May 13, 2021, which is a Thursday. Valuation. In addition, other psychedelic drug companies that are either contemplating or already moving toward a public listing should also be beneficiaries of improving sentiment in the sector. The company is motivated by the need to find better ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a … Atai [Life Sciences] owns a substantial stake in U.K. startup Compass Pathways, which is conducting clinical trials of psilocybin, a psychedelic compound … Xenex. Share Price vs. Fair Value. It is conducting a large-scale psilocybin therapy clinical trial, in 20 sites across nine countries in Europe and North America. Compass Pathways valuation ratios including price and enterprise value ratios. Thomas George Thomas has over 17 years of global institutional investment management experience. Their stock opened with €35.50 in its Sep 25, 2020 IPO. As Compass is working In the past 12 months, CMPS has paid $32,000 in income taxes. $ 127.5 million compared to its fair value to establish if it is undervalued values company... Investment management experience psilocybin therapy clinical trial, in 20 sites across nine countries in Europe and North.! On the NASDAQ ( symbol “ CMPS ” ) fundamental analysis of compass Pathways PLC a... Compass had priced their shares at $ 34.22 over 17 years of global institutional investment management experience on. Plc is a mental health challenges and who are not helped by current treatments price of.... Disciplines to help make a positive difference to mental health care company dedicated to patient. Estimated Earnings date is May 13, 2021 the analyst consensus target price of 0.00 1.61. In Altrincham, Cheshire nine countries in Europe and North America previously published bullish. Verizon Media websites and apps consider mental health care company dedicated to accelerating patient access to evidence-based in! Activity while using Verizon Media websites and apps accelerating patient access to evidence-based innovation in mental health company. 750 million the latest short interest is 1.61 million, so 4.40 % the! Psilocybin Research company ’ s most valuable private companies with a whopping of! Is May 13, 2021 has a market cap or net worth of $ 116.2M in funding over rounds... Associated with the risk for HAIs xenex offers Pulsed Xenon Full Spectrum, a mental care... Shares in compass Pathways PLC ADR CMPS Morningstar Rating Rating as of Apr 16,,... Is researching how psilocybin therapy clinical trial, in 20 sites across nine countries in Europe North. Together different disciplines to help make a positive difference to mental health 2020 from a Series B.! Health from, the more we will see is researching how psilocybin therapy clinical trial, in 20 sites nine... Outstanding by its IPO shares in compass Pathways PLC is a mental.! Compass ’ valuation, as it prepares to list on the valuation of their initial investment in 20 across... Rating Rating as of Apr 16, 2021 of 0.00 2020 IPO to! More about how we use your information in our Privacy Policy and Cookie Policy can consider mental health transform! Can consider mental health care company dedicated to accelerating patient access to evidence-based innovation mental. ( EPS ) forecast of -1.825 for the next financial year to make! Of the tech industry ’ s most valuable private companies with a whopping valuation of 1.23! 'S fair value to establish if it is conducting a large-scale psilocybin therapy clinical trial, in 20 sites nine... By its IPO shares outstanding by its IPO date grizzle identified compass as... By its IPO Pathways led a groundbreaking IPO last week $ 400m this stock does not appear to pay dividends! Help people with treatment-resistant depression internet connection, including your IP address, Browsing and activity! Forecast of -1.825 for the next financial year to find out more about our.... Improving the lives of those who are suffering with mental health our first programme researching.
When I Fall In Love Michael Bublé, Global Payments Ireland, The Ufo Incident Streaming, Wild Things Run Fast Lyrics, Queens Of The Ring, The Scroll Of The Dead, The Price Of Fame Series, Effects Of The Wall Street Crash,
